Background
==========

Pneumonia is an increasing problem among the elderly. In the U.S. the incidence rate of community-acquired pneumonia (CAP) is estimated to be 5.2 to 6.1 cases per 1000 adults, and the mortality rate may reach 2--3% \[[@b1-medscimonit-21-625]\]. Several independent risk factors for pneumonia have been identified, such as increasing age, comorbidities, swallowing dysfunction, and nutritional status. Host genetic susceptibility has also been reported to be an important risk factor for pneumonia \[[@b2-medscimonit-21-625],[@b3-medscimonit-21-625]\].

Toll-like receptors (TLRs) are transmembrane proteins that recognize infection with various pathogens and damaged host cells, which lead to the subsequent inflammation responses \[[@b4-medscimonit-21-625]\]. *TLR4* is a well-studied TLR. *TLR4* can distinguish between lipopolysaccharide and Gram-negative bacteria, and can initiate intracellular signal cascades \[[@b5-medscimonit-21-625]\]. Standiford et al. showed that *TLR4* played a protective role in lung epithelium during Gram-negative bacterial pneumonia \[[@b6-medscimonit-21-625]\]. Tang et al. found that decreased *TLR4* expression occurred in deceased patients compared with survivors \[[@b7-medscimonit-21-625]\]. Furthermore, Tanaka et al. found that *TLR4* agonistic monoclonal antibody UT12 could improve the prognosis of secondary pneumococcal pneumonia \[[@b8-medscimonit-21-625]\]. These results suggest that *TLR4* might influence the development of pneumonia.

Previous studies have found 2 single-nucleotide polymorphisms (SNPs) of *TLR4*: *TLR4* A299G and *TLR4* T399I \[[@b9-medscimonit-21-625]\]. Figueroa et al. suggested that *TLR4* A299G polymorphism impaired LPS-induced phosphorylation of p38 and TANK-binding kinase 1, activation of NF-κB and IFN regulatory factor 3, and induction of IL-8 and IFN-β mRNA \[[@b10-medscimonit-21-625]\]. In addition, Long et al. found that the *TLR4* A299G variant, but not the T399I variant, was responsible for impaired responsiveness of *TLR4* to LPS and corresponding activation of NF-κB \[[@b11-medscimonit-21-625]\]. Recently, studies assessed the association between *TLR4* A299G polymorphism and the risk of pneumonia \[[@b12-medscimonit-21-625]--[@b19-medscimonit-21-625]\], but the results were inconclusive and mixed. We thus conducted this meta-analysis to investigate the association between *TLR4* A299G polymorphism and the risk of pneumonia.

Material and Methods
====================

Publication search
------------------

Relevant studies were systematically searched for by using the NCBI, Medline, Web of Science, and Embase databases (he last retrieval date was August 29, 2014, using the search terms: "pneumonia" and "'Toll like receptor 4" or "*TLR4*"). All discovered studies were retrieved and only published studies with full-text articles were included. For publications with duplicates, only the newest study was used in this research.

Inclusion and exclusion criteria
--------------------------------

The inclusion criteria was: (1) the diagnosis of pneumonia was confirmed by X-ray or CT; (2) the research was a case-control study or a cohort study; (3) the study focused on the association between the *TLR4* A299G polymorphism and the risk of pneumonia; and (4) the *TLR4* A299G genotype of individual groups were provided, The exclusion criteria were: (1) pneumonia was not confirmed by X-ray or CT; (2) animal studies; and (3) reviews or abstracts.

Data extraction
---------------

Based on the selection criteria, 2 reviewers (Xingjun Cai and Yihui Fu) extracted and sorted the data independently (including author, year, ethnicity, age, type, and sample size). Authors were contacted by email if further study details are needed.

Statistical analysis
--------------------

Statistical analysis was conducted using Stata software 11.0 (StataCorp, College Station, Texas, USA). HWE test in the healthy control group was conducted using χ^2^ test. Odds ratio (OR) with a 95% confidence interval (CI) was presented for dichotomous data, and significant level was 0.05. *Q* statistic and *I^2^* statistic were used to measure statistical heterogeneity and significant level was 0.10. Effect model selection was on the basis of heterogeneity test. A fixed-effects model was selected when no significant heterogeneity, otherwise we used a random-effects model. We performed a cumulative meta-analysis by sequential random-effects pooling, starting with the earliest studies. Each successive meta-analysis then summarized all the trials in the preceding years. Results were presented as a series of mini meta-analyses, which were ordered chronologically in a forest plot to show the consequence of adding studies on the effect size. To evaluate the effect of individual studies on overall risk of pneumonia, we conducted sensitivity analyses by excluding each study individually and recalculating the ORs and 95% CI. Funnel plots were performed to estimate potential publication bias, with an asymmetrical plot suggesting possible publication bias. The asymmetry was assessed using the Egger's linear regression test and *P*\<0.05 was considered to represent statistically significant publication bias.

Results
=======

Study characteristics
---------------------

The study selection procedure is shown in [Figure 1](#f1-medscimonit-21-625){ref-type="fig"}. All the studies were performed in Caucasian populations. Only 1 study used pediatric patients, while 7 studies used adult patients. Only 1 study assessed ventilator-associated pneumonia (VAP) patients, while other studies used CAP patients. A total of 658 patients and 1862 controls were included in our meta-analysis. The characteristics of the included studies are listed in [Table 1](#t1-medscimonit-21-625){ref-type="table"}.

Quantitative data synthesis
---------------------------

We investigated the association between *TLR4* A299G polymorphism and pneumonia risk in the recessive models. Result of this meta-analysis showed that *TLR4* A299G polymorphism was significantly associated with pneumonia risk (OR=1.74; 95% CI 1.19--2.53; *P*=0.004; [Figure 2](#f2-medscimonit-21-625){ref-type="fig"}). When we deleted the pediatric study, the result was not changed (OR=1.81; 95% CI 1.22--2.69; *P*=0.003). When the VAP study was deleted, the result was also not changed (OR=1.67; 95% CI 1.06--2.62; *P*=0.03).

To determine the stability of the result, we performed sensitivity analysis by omitting 1 study at a time. We found that single study did not impact the pooled OR, indicating that the results of our research are statistically robust ([Figure 3](#f3-medscimonit-21-625){ref-type="fig"}). Cumulative meta-analysis was also conducted by the assortment of studies by publication time ([Figure 4](#f4-medscimonit-21-625){ref-type="fig"}).

There was no publication bias in this meta-analysis, because no funnel plot asymmetry was detected ([Figure 5](#f5-medscimonit-21-625){ref-type="fig"}). No significant publication bias was found with Begg's test (*P*=0.912).

Discussion
==========

This meta-analysis of 8 case-control studies evaluated the association between *TLR4* A299G polymorphism and the risk of pneumonia. We found that *TLR4* A299G polymorphism might be a risk factor for developing pneumonia. This result suggests that *TLR4* 299AA genotype carriers might have increased pneumonia risk compared to the AG or GG carriers. The result remained significant in adults. In addition, we also found that *TLR4* A299G polymorphism was associated CAP risk. Since there was only 1 study each with pediatric patients and VAP patients, more studies in these populations are needed to validate the result of this meta-analysis.

Previous studies have assessed the association between *TLR4* A299G polymorphism and infectious diseases. For example, Panayiotis et al. did a meta-analysis and showed that *TLR4* A299G polymorphism increased risk for all parasitic infections, malaria, brucellosis, cutaneous leishmaniasis, neurocysticercosis, *Streptococcus pyogenes* tonsillar disease, typhoid fever, and adult urinary tract infections \[[@b20-medscimonit-21-625]\]. However, no study evaluated the association between *TLR4* A299G polymorphism and pneumonia. Thus, to the best of our knowledge, this is the first meta-analysis of the association between *TLR4* A299G polymorphism and pneumonia risk.

A recent study suggested that deficient recruitment of signaling adapters MyD88 and TRIF to *TLR4* was a mechanistic basis for A299G-mediated impairment of *TLR4*-elicited, LPS-induced activation of MyD88-dependent IL-8 and TNF-α genes, deficient TRIF-dependent phosphorylation of TBK1 and IRF3, transactivation of IRF3, and expression of IFN-β mRNA \[[@b10-medscimonit-21-625],[@b21-medscimonit-21-625]\]. Thus, it is important to pay more attention to the subjects with *TLR4* A299G polymorphism.

Conclusions
===========

This meta-analysis had several limitations. Firstly, the sample size for this SNP was relatively small. Thus, the statistical power of genetic effects identified might be hampered. However, results from cumulative meta-analysis and sensitivity analysis suggest that our results are reliable and robust. Secondly, pneumonia is a complex process modulated by a series of genetic factors beyond *TLR4*. However, our analysis only tried to explore the effect of *TLR4* A299G polymorphism on pneumonia, and did not link other gene variants that may be involved in pathophysiological pathways. Therefore, larger clinical studies are required to validate the hypothesis and findings obtained in this study. Once validated, they can be very helpful evidence in developing tailored therapeutics for individual patients.

The results of this meta-analysis suggest that susceptibility to pneumonia is associated with *TLR4* A299G polymorphism.
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###### 

Characteristics of the studies included in meta-analysis.

  First author       Year   Ethnicity   Age group   Pneumonia type   Case number (n)   Control number (n)
  ------------------ ------ ----------- ----------- ---------------- ----------------- --------------------
  Hawn               2005   Caucasian   Adult       CAP              108               508
  Moens              2007   Caucasian   Adult       CAP              72                178
  Everett            2007   Caucasian   Adult       CAP              85                167
  Yuan               2008   Caucasian   Adult       CAP              85                409
  Carvalho           2009   Caucasian   Adult       CAP              87                134
  Kumpf              2010   Caucasian   Adult       VAP              159               176
  Esposito           2012   Caucasian   Pediatric   CAP              18                164
  Rodriguez-Osorio   2013   Caucasian   Adult       CAP              44                126

CAP -- community-acquired pneumonia; VAP -- ventilator-associated pneumonia.
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